Koninklijke DSM NV (DSMN)

170.35
+1.85(+1.10%)
  • Volume:
    284,675
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    167.70 - 170.70

DSMN Overview

Prev. Close
168.5
Day's Range
167.7-170.7
Revenue
8.11B
Open
168.55
52 wk Range
126.45-170.7
EPS
2.64
Volume
284,675
Market Cap
29.34B
Dividend (Yield)
2.40
(1.45%)
Average Vol. (3m)
319,504
P/E Ratio
63.75
Beta
0.68
1-Year Change
30.22%
Shares Outstanding
172,219,339
Next Earnings Date
Aug 03, 2021
What is your sentiment on Koninklijke DSM NV?
or
Market is currently closed. Voting is open during market hours.

Koninklijke DSM NV News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy

Koninklijke DSM NV Company Profile

Koninklijke DSM NV Company Profile

Employees
23127

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.